Nuwellis (NUWE) EBITDA Margin (2013 - 2026)

Nuwellis (NUWE) reported EBITDA Margin of 188.97% for Q1 2026, down 3057.0% on a YoY basis from 6.39% in Q1 2025, and down 94.1% quarter-over-quarter from 97.36% in Q4 2025.

Nuwellis (NUWE) EBITDA Margin (2013 - 2026) Analysis & Trends

Nuwellis has reported EBITDA Margin for 14 years, with the latest figure at 188.97% in Q1 2026.

  • For the quarter ending Q1 2026, EBITDA Margin fell 3057.0% year-over-year to 188.97%; the trailing twelve-month figure through Mar 2026 stood at 216.58% (down 10439.0% YoY), and the FY2025 full-year result was 211.2%, down 8327.0% from the prior year.
  • EBITDA Margin for Q1 2026 stood at 188.97%, down from 97.36% in the prior quarter.
  • The five-year high for EBITDA Margin was 99.45% in Q3 2024, with the low at 728.0% in Q2 2025.
  • Historically, EBITDA Margin has averaged 196.43% across 5 years, with a median of 188.97% in 2026.
  • Annual changes were most pronounced in 2024 — EBITDA Margin jumped 23917 bps — and 2025, when it plunged 37581 bps.
  • Nuwellis' EBITDA Margin stood at 77.98% in 2022, then tumbled by 180 bps to 218.42% in 2023, then soared by 71 bps to 63.26% in 2024, then slumped by 54 bps to 97.36% in 2025, then slumped by 94 bps to 188.97% in 2026.
  • The last three EBITDA Margin figures came in at 188.97% (Q1 2026), 97.36% (Q4 2025), and 21.06% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn 12.05%
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn 15.55%
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn 16.24%
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn 21.16%
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn 28.97%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 14.52%
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn 21.42%
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 10.04%
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn 19.94%
10 Nuwellis 279,710.00 -1.80 Mn 1.68 Mn -188.97%

Historic Data

Download Data
DateValue
Mar 31, 2026 -188.97%
Dec 31, 2025 -97.36%
Sep 30, 2025 21.06%
Jun 30, 2025 -728.00%
Mar 31, 2025 -158.40%
Dec 31, 2024 -63.26%
Sep 30, 2024 99.45%
Jun 30, 2024 -352.19%
Mar 31, 2024 -233.66%
Dec 31, 2023 -218.42%
Sep 30, 2023 -139.72%
Jun 30, 2023 -233.45%
Mar 31, 2023 -355.20%
Dec 31, 2022 -77.98%
Sep 30, 2022 -187.31%
Jun 30, 2022 -193.63%
Mar 31, 2022 -232.35%
Dec 31, 2021 -265.23%
Sep 30, 2021 -284.51%
Jun 30, 2021 -188.64%